GP Vivas · respiratory-health
Community-acquired pneumonia — structured viva
Structured oral on community-acquired pneumonia: defending CURB-65 severity scoring, interpreting CDC aetiology data, corticosteroid evidence for hospitalised patients, the antibiotic duration evidence gap, and failure-to-improve management.
On this page
Study tools
Target exams
RACGP CCEFRACGP oralsMRCGP SCA
Prompt
The examiner opens: 'Every chest infection needs antibiotics — that is safe practice.' The viva branches through aetiology data, severity scoring, corticosteroid evidence, antibiotic duration, and failure-to-improve management.
Stem
A registrar prescribes antibiotics for every cough with fever. The examiner asks you to present a more nuanced approach. [1]
References4ShowHide
- [1]Jones BE, Jones J, Bewick T, Lim WS, Aronsky D, et al. CURB-65 pneumonia severity assessment adapted for electronic decision support. Chest, 2011.PMID 21163875
- [2]Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med, 2015.PMID 26172429
- [3]López-Alcalde J, Rodriguez-Barrientos R, Redondo-Sánchez J, Muñoz-Gutiérrez J, Molero García JM, et al. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database Syst Rev, 2018.PMID 30188565
- [4]Bergmann F, Pracher L, Sawodny R, Blaschke A, Gelbenegger G, et al. Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials. Clin Infect Dis, 2023.PMID 37876267